Ignite Creation Date:
2024-05-05 @ 4:56 PM
Last Modification Date:
2024-10-26 @ 9:26 AM
Study NCT ID:
NCT00350870
Status:
COMPLETED
Last Update Posted:
2014-12-03
First Post:
2006-07-07
Brief Title:
CBT With Disulfiram and Contingency Management
Sponsor:
Yale University
Organization:
Yale University
Study Overview
Official Title:
Maximizing the Efficacy of Cognitive Behavioral Therapy With Medication and Contingency Management
Status:
COMPLETED
Status Verified Date:
2014-11
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This is a study of four treatments for chronic cocaine use and may help study participants to control their drug use All participants will receive weekly individual cognitive behavioral therapy CBT
Detailed Description:
This study will compare four types of treatment involving skills training and incentives for attending sessions or taking study medication Disulfiram is a widely prescribed deterrent to alcohol use In addition to weekly cognitive behavioral therapy CBT participants will be assigned to one of the following treatments
1 placebo
2 disulfiram
3 placebo plus incentives for cocaine abstinence and medication compliance prize CM
4 disulfiram plus incentives for cocaine abstinence and medication compliance
1 placebo
2 disulfiram
3 placebo plus incentives for cocaine abstinence and medication compliance prize CM
4 disulfiram plus incentives for cocaine abstinence and medication compliance
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| 5R01DA019078 | NIH | None | httpsreporternihgovquickSearch5R01DA019078 |